Andres Hurtado-lorenzo PhD

Andres Hurtado-Lorenzo is the Senior Vice President of Translational Research & IBD Ventures at the Crohn's and Colitis Foundation. He is responsible for planning and overseeing the Foundation's translational research portfolio that aims to advance solutions for patients based on research in the fields of Precision Medicine, Genetics, Microbiome, Environmental Triggers, Fibrosis, Pain, and Biosensors. He started and has been leading, from its inception, the Foundation’s venture philanthropy program, IBD Ventures, that advances new products for IBD by investing in for-profit and non-profit organizations.

He is a translational scientist leader with proven success directing multidisciplinary drug discovery and development teams in the biotech and pharmaceutical industry (Wyeth, Pfizer, Proteostasis Therapeutics), resulting in the development of clinical candidate drugs. He obtained his Ph.D. in Molecular Medicine & Gene Therapy from the University of Manchester in England, where he pioneered work in gene therapy for neurodegenerative diseases. He completed his postdoctoral work at Harvard Medical School, Massachusetts General Hospital, and Columbia University.